| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |